These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 15592807

  • 1. [Apomorphine in the treatment of Parkinson's Disease].
    Dressler D.
    Nervenarzt; 2005 Jun; 76(6):681-9. PubMed ID: 15592807
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
    Deleu D, Hanssens Y, Northway MG.
    Drugs Aging; 2004 Jun; 21(11):687-709. PubMed ID: 15323576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.
    Colzi A, Turner K, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):573-6. PubMed ID: 9598668
    [Abstract] [Full Text] [Related]

  • 5. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ, Obering C.
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [Abstract] [Full Text] [Related]

  • 6. Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians.
    Henriksen T.
    Neurodegener Dis Manag; 2014 Nov; 4(3):271-82. PubMed ID: 25095821
    [Abstract] [Full Text] [Related]

  • 7. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
    Zoldan J, Merims D, Kuritzky A, Ziv I, Melamed E.
    Harefuah; 1999 Nov 15; 137(10):444-6, 512, 511. PubMed ID: 10959339
    [Abstract] [Full Text] [Related]

  • 8. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ, Turner K, Lees AJ.
    Mov Disord; 2002 Nov 15; 17(6):1235-41. PubMed ID: 12465062
    [Abstract] [Full Text] [Related]

  • 9. Apomorphine in patients with Parkinson's disease.
    Muguet D, Broussolle E, Chazot G.
    Biomed Pharmacother; 1995 Nov 15; 49(4):197-209. PubMed ID: 7669939
    [Abstract] [Full Text] [Related]

  • 10. [Apomorphine in treatment of Parkinson's disease with fluctuations].
    Zaleska B, Domzał T.
    Neurol Neurochir Pol; 1999 Nov 15; 33(6):1297-303. PubMed ID: 10791032
    [Abstract] [Full Text] [Related]

  • 11. Practical considerations in the use of apomorphine injectable.
    Bowron A.
    Neurology; 2004 Mar 23; 62(6 Suppl 4):S32-6. PubMed ID: 15037670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apomorphine: an underutilized therapy for Parkinson's disease.
    Poewe W, Wenning GK.
    Mov Disord; 2000 Sep 23; 15(5):789-94. PubMed ID: 11009181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.
    Olanow CW, Factor SA, Espay AJ, Hauser RA, Shill HA, Isaacson S, Pahwa R, Leinonen M, Bhargava P, Sciarappa K, Navia B, Blum D, CTH-300 Study investigators.
    Lancet Neurol; 2020 Feb 23; 19(2):135-144. PubMed ID: 31818699
    [Abstract] [Full Text] [Related]

  • 16. Rotigotine for the treatment of Parkinson's disease.
    Morgan JC, Sethi KD.
    Expert Rev Neurother; 2006 Sep 23; 6(9):1275-82. PubMed ID: 17009915
    [Abstract] [Full Text] [Related]

  • 17. Apomorphine in the treatment of Parkinson's disease.
    Hagell P, Odin P.
    J Neurosci Nurs; 2001 Feb 23; 33(1):21-34, 37-8. PubMed ID: 11233359
    [Abstract] [Full Text] [Related]

  • 18. Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?
    Montastruc JL, Rascol O, Senard JM, Houin G, Rascol A.
    J Neural Transm Suppl; 1995 Feb 23; 45():157-61. PubMed ID: 8748621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.